Clinical efficacy comparison of avapritinib with other tyrosine kinase inhibitors in gastrointestinal stromal tumors with PDGFRA D842V mutation: a retrospective analysis of clinical trial and real-world data
- Margaret von Mehren
- , Michael C. Heinrich
- , Hongliang Shi
- , Sergio Iannazzo
- , Raymond Mankoski
- , Saša Dimitrijević
- , Gerard Hoehn
- , Silvia Chiroli
- , Suzanne George
- Oregon Health and Science University
- Blueprint Medical Corporation
- Dana-Farber Cancer Institute
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations